Welcome
Support Centre
17 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Study of colonoscopic surveillance intervals after removal of colorectal adenomas
ISRCTN ISRCTN02411483
ClinicalTrials.gov identifier
Public title Study of colonoscopic surveillance intervals after removal of colorectal adenomas
Scientific title Randomised trial of colonoscopic surveillance intervals after removal of colorectal adenomas
Acronym N/A
Serial number at source HTA 04/33/01
Study hypothesis The study was designed to compare the effectiveness of different frequencies of colonoscopic examination, with polypectomy of all adenomas detected, for preventing advanced adenomas and colorectal cancer (CRC).

A secondary aim of this study was to identify baseline risk factors for diagnosis of advanced neoplasia (adenomas and CRC) during follow-up. This approach was adopted to determine if a subgroup of patients might benefit from more intense surveillance.
Lay summary Not provided at time of registration
Ethics approval Not applicable because ethical approval standards were not in place when the study was started in the late 1970s – early 1980s.
Study design Single-centre stratified randomised trial
Countries of recruitment United Kingdom
Disease/condition/study domain Colorectal cancer
Participants - inclusion criteria 1. Patients attending St Mark’s Hospital between 1979-1990, with endoscopically removed adenomas or malignant lesions
2. 468 males and 317 females in the study, aged between 20 and 71
Participants - exclusion criteria 1. History of inflammatory bowel disease
2. Surgical resection for CRC
3. A rectal villous adenoma
4. Patients older than 70 years
Anticipated start date 01/01/1979
Anticipated end date 01/01/1990
Status of trial Completed
Patient information material
Target number of participants 785 patients were recruited
Interventions Study of colonoscopic surveillance regimens. Allocation to regimen was by minimisation method. Patients were stratified into high and low risk groups by their characteristics at entry (age, malignancy and multiplicity of adenomas). Then within the high risk group the participants could be randomised to frequent follow-up or exams at three year intervals. Within the low risk group paricipants could be randomised to exams at three year intervals or exams at five year intervals. No masking, all participants received surveillance.

High risk patients:
Three exams at 12-18 month intervals and 3-yearly follow-up thereafter (median endoscopic surveillance - 7.0 yrs, median passive follow-up - 18.6 yrs) or exams at three year intervals (median endoscopic surveillance - 6.6 yrs, median passive follow-up - 18.8 yrs)

Low risk patients:
Exams at three year intervals (median endoscopic surveillance - 9.1 yrs, median passive follow-up - 21.7 yrs) or exams at five year intervals (median endoscopic surveillance - 6.3 yrs, median passive follow-up - 21.8 yrs)
Primary outcome measure(s) The primary outcome was the diagnosis of advanced neoplasia (advanced adenomas or colorectal cancer) during follow-up. An advanced adenoma was defined as an adenoma ≥ 10 mm or with high grade dysplasia.
Secondary outcome measure(s) Detection of any adenoma during follow-up.
Sources of funding 1. NIHR Health Technology Assessment Programme - HTA (UK) (HTA 04/33/01)
2. Cancer Research UK (CRUK) (UK) (grant numbers C8649/A7479, C8171/A7699)
Trial website
Publications
Contact name Prof  Wendy S  Atkin
  Address Imperial College London
St. Mary's Campus
Norfolk Place
  City/town London
  Zip/Postcode W2 1PG
  Country United Kingdom
  Tel +44 (0)20 7594 3369
  Fax +44 (0)20 7594 3051
  Email w.atkin@imperial.ac.uk
Sponsor Imperial College London (UK)
  Address Clinical Research Governance Office
G02, Sir Alexander Fleming Building
South Kensington Campus
  City/town London
  Zip/Postcode SW7 2AZ
  Country United Kingdom
  Tel +44 (0)20 7594 1554
  Fax +44 (0)20 7594 1792
  Email clinicalresearchgovernanceoffice@imperial.ac.uk
Date applied 07/06/2011
Last edited 08/06/2011
Date ISRCTN assigned 08/06/2011
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central